Fructosamine; is the current interest in alternative glycaemic markers justified?
MetadataShow full item record
CitationShipman K. E., Jawad, M., Sullivan, K. M., Ford, C., and Gama, R. (2015) Fructosamine; is the current interest in alternative glycaemic markers justified? Diabetic Medicine, 32 (8), pp. 1116-1117, DOI: 10.1111/dme.12767
PubMed ID25819596 (pubmed)
DescriptionThis is an accepted manuscript of an article published by Wiley in Diabetic Medicine on 27/03/2015, available online: https://doi.org/10.1111/dme.12767 The accepted version of the publication may differ from the final published version.
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/
- Fructosamine; is the current interest in alternative glycaemic markers justified?
- Authors: Shipman KE, Jawad M, Sullivan KM, Ford C, Gama R
- Issue date: 2015 Aug
- The agreement between fasting glucose and markers of chronic glycaemic exposure in individuals with and without chronic kidney disease: a cross-sectional study.
- Authors: George C, Matsha TE, Korf M, Zemlin AE, Erasmus RT, Kengne AP
- Issue date: 2020 Jan 30
- Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
- Authors: Konya J, Ng JM, Cox H, Cooke M, Lewis N, Bhandari S, Atkin SL, Kilpatrick ES
- Issue date: 2013 Oct
- Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
- Authors: Rooney MR, Tang O, Pankow JS, Selvin E
- Issue date: 2021 Feb